Natco Pharma (BOM:524816) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Natco Pharma's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Natco Pharma's Revenue for the three months ended in Mar. 2024 was ₹10,683 Mil. Therefore, Natco Pharma's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Natco Pharma's current FCF Yield % is 4.61%.

The historical rank and industry rank for Natco Pharma's FCF Margin % or its related term are showing as below:

BOM:524816' s FCF Margin % Range Over the Past 10 Years
Min: -10.3 Med: 2.86 Max: 23.77
Current: 21.33

During the past 13 years, the highest FCF Margin % of Natco Pharma was 23.77%. The lowest was -10.30%. And the median was 2.86%.

BOM:524816's FCF Margin % is ranked better than
91.89% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.085 vs BOM:524816: 21.33

Natco Pharma FCF Margin % Historical Data

The historical data trend for Natco Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma FCF Margin % Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

3.11

2.61

-10.30

23.77

21.33

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Natco Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Natco Pharma's FCF Margin % falls into.

Natco Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Natco Pharma's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	8529	/	39988
	=	21.33 %

Natco Pharma's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	10683
	=	0.00 %

Natco Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Natco Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (BOM:524816) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » FCF Margin %

Traded in Other Exchanges

NATCOPHARM:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines